Skip to main content

Table 1 Baseline sociodemographic characteristics and risk factors for cervical disease at enrolment

From: Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa

 

No. of subjects (%)

 

HIV negative

HIV positive

 

Cryotherapy arm, (n = 271)

Control arm, (n = 269)

Cryotherapy arm, (n = 38)

Control arm, (n = 34)

Age, years:

    

   35-39

110 (40.6)

114 (42.4)

19 (50.0)

21 (61.8)

   40-49

124 (45.8)

116 (43.1)

18 (47.4)

9 (26.5)

   50-65

37 (13.7)

39 (14.5)

1 (2.6)

4 (11.8)

Education:

    

   No school

28 (10.3)

28 (10.4)

3 (7.9)

3 (8.8)

   Some primary school

103 (38.0)

98 (36.4)

13 (34.2)

11 (32.4)

   Some high school

108 (39.9)

103 (38.3)

17 (44.7)

13 (38.2)

   High school graduate

32 (11.8)

40 (14.9)

5 (13.2)

7 (20.6)

Currently employed

73 (26.9)

70 (26.0)

10 (26.3)

3 (8.8)

Married

141 (52.0)

150 (55.8)

13 (34.2)

12 (35.3)

Age < 16 years at first sexual intercourse

98 (36.2)

102 (37.9)

12 (31.6)

13 (38.2)

≥ 5 Lifetime sex partners

84 (31.0)

82 (30.5)

17 (44.7)a

24 (70.6)a

≥ 2 Sex partners during previous month

3 (1.1)

4 (1.5)

1 (2.6)

1 (2.9)

Current smoker

21 (7.8)

19 (7.1)

6 (15.8)

4 (11.8)

Current contraceptive use:

    

   Injectable

57 (21.0)

44 (16.4)

10 (26.3)

9 (26.5)

   Oral

10 (3.7)

5 (1.9)

0

2 (5.9)

No. of live births:

    

   None

5 (1.9)

10 (3.7)

0

3 (8.8)

   1-4

181 (66.8)

184 (68.4)

29 (76.3)

24 (70.6)

   ≥ 5

85 (31.4)

75 (27.9)

9 (23.7)

7 (20.6)

Cytologic abnormality (ASCUS or greater)

15 (5.5)

20 (7.4)

2 (5.3)

3 (8.8)

Chlamydia trachomatis or Neisseria gonorrhoeae

16 (5.9)

13 (4.8)

6 (15.8)

2 (5.9)

Trichomonas vaginalis

30 (11.1)

25 (9.3)

3 (7.9)

4 (11.8)

  1. a P value < 0.05 for comparisons between the cryotherapy and control group.
  2. ASCUS = atypical squamous cells of undetermined significance.